Screening for prostate cancer: First, standardise the assay

BMJ (Online)

Volumn 341, Issue 7779, 2010, Pages 903-

  Howell, Ann Marie R ^a   Parnham, Arie ^a   Karim, Omer ^a   Kavia, Rajesh ^a  

^a WEXHAM PARK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ANXIETY; CANCER DIAGNOSIS; CANCER SCREENING; DIAGNOSTIC ERROR; HEALTH CARE QUALITY; HUMAN; LETTER; NATIONAL HEALTH ORGANIZATION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; STANDARDIZATION; UNITED KINGDOM; WORLD HEALTH ORGANIZATION; BLOOD; DIAGNOSTIC TEST; MALE; PROSTATE TUMOR; STANDARD;

DIAGNOSTIC TESTS, ROUTINE; HUMANS; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 78049469042     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.c5813     Document Type: Letter

References (5)

1. Andriole GL, Jr. Screening for prostate cancer. BMJ 2010;341:c4538. (14 September.) [FREE Full text]
2. National Institute for Health and Clinical Excellence. Prostate cancer: diagnosis and treatment. 2008. www.nice.org.uk/CG058fullguideline.
3. WHO Drug Information 1999;13(4), http://apps.who.int/medicinedocs/en/d/ Jh1461e/1.html.
4. NHS Purchasing and Supply Agency. Evaluation report. Total PSA assays. CEP09004. 2009.
5. Rosario DJ, Lane JA, Metcalfe C, Catto JW, Dedman D, Donovan JL, et al. Contribution of a single repeat PSA test to prostate cancer risk assessment: experience from the ProtecT study. Eur Urol 2008;53:777-84. [CrossRef] [Medline] [Web of Science]